Masimo Q2 revenue $455M, EPS $0.29 GAAP; cuts FY guidance to $2.1-2.2B

MASIMO CORP

2023-Q2 EPS reported $0.68 revenue$1,020,300,000

Consolidated revenue $455.3M (healthcare $281.1M, non-healthcare $174.2M); GAAP EPS $0.29, non-GAAP $0.62.
GAAP operating income $29.3M, non-GAAP $58.6M; 64,100 noninvasive tech board shipments.
CEO disappointed; record hospital customer gains but inpatient volumes below expectations.
Updated Q3 2023 revenue guidance $475-525M; full-year revenue $2.1-2.2B (down from prior).
Full-year GAAP EPS guidance $1.91-2.11; non-GAAP $3.35-3.55.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

MASIMO CORP reported second quarter of 2023, ended July 1, 2023 results: revenue $455.3 million, net income $15.7 million, or $0.29 per diluted share, EPS $0.29 per diluted share.

Period: second quarter of 2023, ended July 1, 2023
Revenue: $455.3 million
Net income: $15.7 million, or $0.29 per diluted share
EPS: $0.29 per diluted share
Result: reported results

Exact text from the filing

by specific reference in such filing. --- EX-99.1 (EX-99.1) --- Masimo Reports Second Quarter 2023 Financial Results Second Quarter 2023 Highlights • Consolidated revenue was $455.3 million; • Healthcare revenue was $281.1 million; • Non-healthcare revenue was $174.2 million; • GAAP net income per diluted share was $0.29; and • Non-GAAP net income per diluted share

View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

MASIMO CORP filing history →

Source: SEC EDGAR

accession 0000937556-23-000193

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.